CF
Carma Fund
Activity from announced rounds
Activity in this selectionAI
Carma Fund is the investment brand named in the Allogenetics and Exciva financing histories.
Recorded funding activity
Allogenetics develops an ex vivo gene-therapy approach that modifies donor organs before transplantation to reduce rejection. Exciva develops therapies for behavioral symptoms associated with Alzheimer’s disease. The covered announcements use the unnumbered brand; they do not identify a particular fund vintage.
- Rounds participated in
- 0
- Confirmed lead rounds
- — All roles disclosed
- New companies
- 0 First participation on record · 0 follow-on
- Funding in participating rounds
- — 0 disclosed · full round size, not this investor’s share
By stage
No activity in this selection.
By primary sector
No activity in this selection.
By country
No activity in this selection.
Rounds
0 in this selectionNo rounds match this selection.